Pharma Mar Sau Stock Filter Stocks by Fundamentals
| 0RC6 Stock | 72.55 2.34 3.12% |
Pharma Mar SAU fundamentals help investors to digest information that contributes to Pharma Mar's financial success or failures. It also enables traders to predict the movement of Pharma Stock. The fundamental analysis module provides a way to measure Pharma Mar's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharma Mar stock.
Pharma | Shares Owned by Insiders |
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Pharma Fundamentals
| Return On Equity | 0.0032 | |||
| Return On Asset | -0.0065 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 1.19 B | |||
| Shares Outstanding | 221.28 M | |||
| Shares Owned By Insiders | 21.39 % | |||
| Shares Owned By Institutions | 7.20 % | |||
| Price To Sales | 98.12 X | |||
| Revenue | 158.15 M | |||
| Gross Profit | 182.7 M | |||
| EBITDA | 4.55 M | |||
| Net Income | 1.14 M | |||
| Total Debt | 43.67 M | |||
| Book Value Per Share | 10.39 X | |||
| Cash Flow From Operations | (13.45 M) | |||
| Earnings Per Share | 5.03 X | |||
| Number Of Employees | 509 | |||
| Beta | 0.044 | |||
| Market Capitalization | 16.39 B | |||
| Total Asset | 341.22 M | |||
| Retained Earnings | 142.22 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 341.22 M | |||
| Last Dividend Paid | 0.65 |
About Pharma Mar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharma Mar SAU's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharma Mar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharma Mar SAU based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pharma Stock Analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.